One problem that all pharmaceutical marketers face is how to convince payers that their innovative treatment is worth paying for. In order to make a compelling argument, pharma must develop a pipeline of "real-world evidence" that demonstrates the utility of treatments and their impact on cost.  Kari Kalgrem from Premier Applied Sciences is working with the pharmaceutical industry on this important work that will help increase patient access.